Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
Retinopathy is a threat to the eyesight, and glaucoma and diabetes are the main causes for the damage of retinal cells. Recent insights pointed out a common pathogenetic pathway for both disorders, based on chronic inflammation. Palmitoylethanolamide (PEA) is an endogenous cell protective lipid. Sin...
Saved in:
Main Authors: | Jan M. Keppel Hesselink, Ciro Costagliola, Josiane Fakhry, David J. Kopsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2015/430596 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retinoprotective therapy of glaucoma
by: A.S. Makarova
Published: (2022-11-01) -
Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold
by: J. M. Keppel Hesselink, et al.
Published: (2013-01-01) -
Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline
by: David J. Kopsky, et al.
Published: (2012-01-01) -
Walking with Neuropathic Pain: Paradoxical Shift from Burden to Support?
by: David J. Kopsky, et al.
Published: (2015-01-01) -
Place of retinoprotective therapy in modern ophthalmologic practice
by: E.A. Egorov, et al.
Published: (2018-07-01)